(Q77219939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

Neerja Kaushik

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Amartya Basu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Virendra N Pandey

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

13-27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

New therapy explains the fall in AIDS incidence with a substantial rise in number of persons on treatment expected.

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Does HIV-1 Tat induce a change in viral initiation rights?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Synthesis of a new class of HIV-1 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Tat-mediated delivery of heterologous proteins into cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Bactericidal antisense effects of peptide-PNA conjugates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Multifaceted activities of the HIV-1 transactivator of transcription, Tat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Control of RNA initiation and elongation at the HIV-1 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

1 reference

7 January 2021

The retroviral enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Peptide nucleic acids as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Conformation of the TAR RNA-Arginine Complex by NMR Spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Regulatory functions of Cdk9 and of cyclin T1 in HIV Tat transactivation pathway gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Fragments of the HIV-1 Tat protein specifically bind TAR RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900024-4

7 January 2021

10.1016/S0166-3542(02)00024-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12323396%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference